You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
金城醫藥(300233.SZ):錦聖基金擬轉讓公司25.05%股權告吹
格隆匯 01-05 20:19

格隆匯1月5日丨金城醫藥(300233.SZ)公佈,2019年9月26日, 公司收到股東北京錦聖投資中心(有限合夥)(以下簡稱"錦聖基金")的《關於股份意向轉讓的告知函》,錦聖基金與德展健康就其持有公司25.05%股權轉讓事宜進行了初步協商,達成了框架性條款,並於2019年9月25日簽訂了《德展大健康股份有限公司與北京錦聖投資中心(有限合夥)關於山東金城醫藥集團股份有限公司股份收購之框架協議》(以下簡稱"框架協議")。2019年11月4日,錦聖基金與德展健康簽訂了《關於山東金城醫藥集團股份有限公司股份收購之框架協議的補充協議》(以下簡稱"補充協議")。

2020年1月4日,公司收到錦聖基金《關於終止與德展健康股份收購合作的告知函》(以下簡稱"告知函")。根據錦聖基金與德展健康簽署的框架協議及補充協議之約定"本框架協議在到期後終止或雙方達成正式交易文件後終止",目前框架協議及補充協議已經到期,錦聖基金與德展健康就具體合作事項未能達成一致意見,經雙方協商一致後同意終止上述合作事宜。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account